Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
Biography and Research Information
OverviewAI-generated summary
Arundhati Chavan's research focuses on understanding disease mechanisms at the cellular and molecular levels, with a stated goal of accelerating disease diagnosis and treatment. Her work investigates how epigenetic modifications, such as DNA methylation, influence cellular processes and contribute to disease development. Chavan has published on the role of DNMT3B and the CBFA2T3-GLIS2 fusion in acute myeloid leukemia (AML), specifically examining their impact on chromatin structure, cell cycle regulation, and apoptotic resistance.
Her publications explore potential therapeutic vulnerabilities within these epigenetic pathways in high-risk pediatric AML. Chavan collaborates with researchers at the University of Arkansas for Medical Sciences, including Samrat Roy Choudhury, Giselle Almeida Gonzalez, and Pritam Biswas. Her research interests also extend to improving diagnostic methods and developing scalable approaches for disease assessment and drug screening.
Metrics
- h-index: 1
- Publications: 4
- Citations: 2
Positions
-
Research Assistant I 2023–presentUniversity of Arkansas for Medical Sciences Pediatric Hematology-Oncology ORCID
Selected Publications
-
Abstract 3496: Epigenetic repurposing by CBFA2T3-GLIS2 reveals a druggable DNA methylation axis in high-risk pediatric AML vulnerability in pediatric AML (2026)
-
Abstract PR006: CBFA2T3–GLIS2 fusion reprograms enhancer-linked DNA methylation to enforce apoptotic resistance and defines an epigenetic vulnerability in pediatric AML (2026)
-
Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia (2025)
Collaboration Network
Top Collaborators
Samrat Roy Choudhury
University of Arkansas for Medical Sciences
3 shared publications
In database
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
- Abstract PR006: CBFA2T3–GLIS2 fusion reprograms enhancer-linked DNA methylation to enforce apoptotic resistance and defines an epigenetic vulnerability in pediatric AML
- Abstract 3496: Epigenetic repurposing by CBFA2T3-GLIS2 reveals a druggable DNA methylation axis in high-risk pediatric AML vulnerability in pediatric AML
Giselle Almeida Gonzalez
University of Arkansas for Medical Sciences
3 shared publications
In database
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
- Abstract PR006: CBFA2T3–GLIS2 fusion reprograms enhancer-linked DNA methylation to enforce apoptotic resistance and defines an epigenetic vulnerability in pediatric AML
- Abstract 3496: Epigenetic repurposing by CBFA2T3-GLIS2 reveals a druggable DNA methylation axis in high-risk pediatric AML vulnerability in pediatric AML
Jason E. Farrar
University of Arkansas for Medical Sciences
3 shared publications
In database
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
- Abstract PR006: CBFA2T3–GLIS2 fusion reprograms enhancer-linked DNA methylation to enforce apoptotic resistance and defines an epigenetic vulnerability in pediatric AML
- Abstract 3496: Epigenetic repurposing by CBFA2T3-GLIS2 reveals a druggable DNA methylation axis in high-risk pediatric AML vulnerability in pediatric AML
Akhilesh Kaushal
Arkansas Children's Hospital
1 shared publication
In database
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
Pritam Biswas
Arkansas Children's Hospital
1 shared publication
In database
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
Cory C. Padilla
Biota Pharmaceuticals (United States) (US)
1 shared publication
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
Jay F. Sarthy
1 shared publication
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
Soheil Meshinchi
Fred Hutch Cancer Center (US)
1 shared publication
- Transcriptional rewiring by enhancer methylation in CBFA2T3-GLIS2–driven pediatric acute megakaryoblastic leukemia
Rhonda E. Ries
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
1 shared publication
- Abstract PR006: CBFA2T3–GLIS2 fusion reprograms enhancer-linked DNA methylation to enforce apoptotic resistance and defines an epigenetic vulnerability in pediatric AML
Soheil Meshinchi
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa (ZA)
1 shared publication
- Abstract PR006: CBFA2T3–GLIS2 fusion reprograms enhancer-linked DNA methylation to enforce apoptotic resistance and defines an epigenetic vulnerability in pediatric AML
Rhonda E. Ries
Fred Hutch Cancer Center (US)
1 shared publication
- Abstract 3496: Epigenetic repurposing by CBFA2T3-GLIS2 reveals a druggable DNA methylation axis in high-risk pediatric AML vulnerability in pediatric AML
Soheil Meshinchi
Fred Hutch Cancer Center (US)
1 shared publication
- Abstract 3496: Epigenetic repurposing by CBFA2T3-GLIS2 reveals a druggable DNA methylation axis in high-risk pediatric AML vulnerability in pediatric AML
Similar Researchers
Based on overlapping research topics
Giselle Almeida Gonzalez
University of Arkansas for Medical Sciences
Acute Myeloid Leukemia Research
Epigenetics and DNA Methylation
Cancer-related molecular mechanisms research
Samrat Roy Choudhury
University of Arkansas for Medical Sciences
Acute Myeloid Leukemia Research
Epigenetics and DNA Methylation
Cancer-related molecular mechanisms research
Stephanie D. Byrum
University of Arkansas for Medical Sciences
Epigenetics and DNA Methylation
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Li Xia
National Center for Toxicological Research
Epigenetics and DNA Methylation
Cancer-related molecular mechanisms research
Disease Mechanisms Research
A. Moerman-Herzog
University of Arkansas for Medical Sciences
Epigenetics and DNA Methylation
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Md Nazmul Huda
University of Arkansas for Medical Sciences
Cancer-related molecular mechanisms research
Disease Mechanisms Research
Genomics and Chromatin Dynamics